Crestline Closes $625M European Capital Solutions Fund II: Asset-Backed Private Credit and Esoteric Collateral Explained

    Crestline Closes $625M European Capital Solutions Fund II: Asset-Backed Private Credit and Esoteric Collateral Explained

    TL;DR: Crestline Management closed its second European Capital Solutions Fund (ECSFII) at $625 million on August 20, 2026 — roughly 75% larger than Fund I — targeting asset-backed private credit deals

    August 23, 2026

    Vista Equity Partners Seeks $3B Sale of Allvue Systems, Nearly Double Its Failed 2021 IPO Price

    Vista Equity Partners Seeks $3B Sale of Allvue Systems, Nearly Double Its Failed 2021 IPO Price

    TL;DR: Vista Equity Partners is running a formal sale process for Allvue Systems at a $2B to $3B valuation, nearly double the $1.7B price the company failed to achieve in a 2021 NYSE IPO. With Evercor

    August 23, 2026

    The SEC's Venture Capital Fund Exemption (Section 203(l) / Rule 203(l)-1): What Every LP Needs to Know

    The SEC's Venture Capital Fund Exemption (Section 203(l) / Rule 203(l)-1): What Every LP Needs to Know

    TL;DR: Section 203(l) of the Investment Advisers Act and its implementing Rule 203(l)-1 let venture capital fund managers skip SEC registration and, more importantly, skip routine SEC examinations. Th

    August 23, 2026

    8-Step Checklist to Vet a Pre-IPO SPV Sponsor Before Committing Capital

    8-Step Checklist to Vet a Pre-IPO SPV Sponsor Before Committing Capital

    TL;DR: In August 2026, the SEC sued Andrew Spaventa for running a $74 million pre-IPO boiler room that charged investors unit prices up to 91% above his actual acquisition cost, and separately sued Er

    August 23, 2026

    Advent International's $1 Billion Bet on NZCR: Why Private Equity Is Targeting Clinical Research Organizations

    Advent International's $1 Billion Bet on NZCR: Why Private Equity Is Targeting Clinical Research Organizations

    TL;DR: On August 20, 2026, Advent International announced a majority-stake acquisition of New Zealand Clinical Research Group (NZCR) in a deal valued at approximately NZD $1 billion. Existing sharehol

    August 22, 2026

    Destiny Tech100 (DXYZ) Review 2026

    Destiny Tech100 (DXYZ) Review 2026

    TL;DR: Destiny Tech100 (NYSE: DXYZ) lets you buy into SpaceX, OpenAI, and Anthropic through a regular brokerage account with no accreditation required. That access is real. As of May 2026, the fund's

    August 22, 2026

    Oakley Capital's Fund VI Bet on Graphwise: What PE's Pivot to Enterprise AI Infrastructure Means for You

    Oakley Capital's Fund VI Bet on Graphwise: What PE's Pivot to Enterprise AI Infrastructure Means for You

    TL;DR: On August 19, 2026, Oakley Capital announced a majority-stake acquisition of Graphwise through its Fund VI, a EUR 4.5 billion vehicle that closed at hard cap. Graphwise is a Vienna- and Sofia-b

    August 22, 2026

    Fee Transparency Is Now a Competence Test, Not a Back-Office Detail

    Fee Transparency Is Now a Competence Test, Not a Back-Office Detail

    TL;DR: Fee transparency has become an early competence signal in private-fund fundraising. As global private-equity fundraising declined in 2025 , professional LPs increasingly read a manager's fee di

    August 22, 2026

    How to Spot a Pre-IPO Share Markup Scheme Before You Wire Money

    How to Spot a Pre-IPO Share Markup Scheme Before You Wire Money

    TL;DR: The SEC's August 2026 complaint against Andrew Spaventa and his three entities (The Spaventa Group LLC, TSG Capital Advisors LLC, and TSG Alpha Partners LLC) describes a $74 million boiler-room

    August 22, 2026

    Francisco Partners Is Taking Weave Communications Private for $650M. Here Is What That Means for Small-Cap Software Investors.

    Francisco Partners Is Taking Weave Communications Private for $650M. Here Is What That Means for Small-Cap Software Investors.

    TL;DR: Francisco Partners announced on August 18, 2026 that it will acquire Weave Communications (NYSE: WEAV) in an all-cash deal worth roughly $650 million, or $7.40 per share — a 34% premium to Weav

    August 22, 2026

    Private Equity Fundraising Just Posted Its Fourth Straight Annual Decline, and the Real Story Is Who's Getting Shut Out

    Private Equity Fundraising Just Posted Its Fourth Straight Annual Decline, and the Real Story Is Who's Getting Shut Out

    TL;DR: Global private equity fundraising fell to roughly $398–$408 billion in 2025, its fourth consecutive annual decline and the weakest total in over a decade. But the headline number buries the rea

    August 22, 2026

    Stone Point and Genstar Are Buying Ascensus. This Is PE's Fourth Pass at the Same Company.

    Stone Point and Genstar Are Buying Ascensus. This Is PE's Fourth Pass at the Same Company.

    TL;DR: Stone Point Capital and Genstar Capital announced on August 18, 2026, that they are acquiring equal stakes in Ascensus, a recordkeeper that administers more than $1.3 trillion in retirement ass

    August 22, 2026